COG-UK Science Showcase

COG-UK Science Showcase - SARS-CoV-2 genomics in action

  • When? Thursday 7th October, 13:00 to 15:30 GMT+1
  • Where? Zoom
  • Who can attend? Everyone
  • What? An afternoon of short talks showcasing the role of SARS-CoV-2 genomics in UK national studies and beyond.

CLICK HERE to register now

13.00 – 13.05 Opening remarks – Professor Sharon Peacock, Executive Director and Chair, COG-UK
13.05 – 13.55 Session 1: Hospital and Vaccine Studies: insights from SARS-CoV-2 sequencing – Chair: Dr Thushan de Silva, University of Sheffield
13.05 – 13.20 The COG-UK Hospital Onset Covid Infection (HOCI) study; harnessing pathogen sequencing for infection prevention and control – Professor Judith Breuer, University College London
13.20 – 13.35 Genomic sequencing of SARS-CoV-2 to understand nosocomial spread and the effects of the Pfizer/BioNTech BNT162b2 vaccine in a UK hospital – Kate Cook, University of Portsmouth
13.35 – 13.55 SARS-CoV-2 Genomics in Oxford Vaccine Trials – Dr Tanya Golubchik, University of Oxford; Contributions of Sequencing to the Interpretation of Vaccine Efficacy in the Novavax UK Phase 3 Trial – Dr Joy Rivers, Novavax
13.55 – 14.25  Session 2: Care Home and University Studies: the impact of viral genomics in different settings – Chair: Professor Emma Thomson, University of Glasgow
13.55 – 14.10 COVID-19 in care homes: the challenges and opportunities for genomic sequencing in the VIVALDI study – Dr Maria Krutikov, University College London
14.10 – 14.25 Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission – Dr Dinesh Aggawal, University of Cambridge
14.30 – 15.15 Session 3: Public Health and National Infection Surveys: the role played by SARS-CoV-2 genomic data – Chair: Dr Theo Sanderson, Wellcome Sanger Institute/Francis Crick Institute
14.30 – 14.45 SARS-CoV-2 Sequencing in support of the ONS COVID-19 Infection Survey – Dr Katrina Lythgoe, University of Oxford
14.45 – 15.00 SARS-CoV-2 lineage dynamics as inferred from representative community samples – what we can learn from the REACT-1 study – Oliver Eales, Imperial College London
15.00 – 15.15 The role played by COG-UK data in the UKHSA genomics cell – Eileen Gallaghar, UK Health Security Agency
15.15 – 15.20 Thanks and close – Professor Sharon Peacock, Executive Director and Chair, COG-UK